UNIRING-OBS SHNCT07949682
Peripheral Perfusion After UNIFUZOL® Versus Lactated Ringer's in Resolving Septic Shock
StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Capillary Refill Time at 6 Hours
Timeframe: 6 hours after start (window ±60 minutes)
Secondary (6)
Thenar NIRS Reoxygenation Slope at 6 Hours
Sustained Macro-Microhemodynamic Coherent Response
Change in Capillary Refill Time Over 24 Hours
Change in ReOx
Change in De-oxygenation slope
Show 1 moreShow less
Change in NIRS Vascular Reactivity Over 24 Hours (tissue oxygenation)
Arms and interventions
UNIFUZOL® exposure cohort
Participants for whom the treating physician independently selected and actually started UNIFUZOL® at T0. The protocol does not determine indication, dose, rate, duration, repeat administration, or subsequent fluids.
Lactated Ringer's exposure cohort
Participants for whom the treating physician independently selected and actually started lactated Ringer's solution at T0. The protocol does not determine indication, dose, rate, duration, repeat administration, or subsequent fluids.